Epidemiology of whooping cough & typing of Bordetella pertussis.

Bordetella pertussis is a Gram-negative human-restricted bacterium that evolved from the broad-range mammalian pathogen, Bordetella bronchiseptica. It causes whooping cough or pertussis in humans, which is the most prevalent vaccine-preventable disease worldwide. The introduction of the pertussis whole-cell vaccination for young children, followed by the introduction of the pertussis acellular vaccination (along with booster vaccination) for older age groups, has affected the bacterial population and epidemiology of the disease. B. pertussis is relatively monomorphic worldwide, but nevertheless, different countries are facing different epidemiological evolutions of the disease. Although it is tempting to link vaccine-driven phenotypic and genotypic evolution of the bacterium to epidemiology, many other factors should be considered and surveillance needs to continue, in addition to studies investigating the impact of current clinical isolates on vaccine efficacy.

[1]  J. Brisson,et al.  Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine era. , 2013, Carbohydrate research.

[2]  I. Martin,et al.  Genetic analysis of Bordetella pertussis in Ontario, Canada reveals one predominant clone. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  Hugues Bedouelle,et al.  In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. , 2013, Microbes and infection.

[4]  N. Guiso,et al.  Virulence of Pertactin-NegativeBordetella pertussisIsolates from Infants, France , 2013 .

[5]  A. Evangelista,et al.  Pertactin-negative variants of Bordetella pertussis in the United States. , 2013, The New England journal of medicine.

[6]  K. Spicer,et al.  Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  F. Mooi,et al.  Pulsed-Field Gel Electrophoresis Analysis of Bordetella pertussis Isolates Circulating in Europe from 1998 to 2009 , 2012, Journal of Clinical Microbiology.

[8]  T. Nicholson,et al.  Identification of a CO2 Responsive Regulon in Bordetella , 2012, PloS one.

[9]  F. Mooi,et al.  Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps , 2012, PloS one.

[10]  G. Dore,et al.  Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  J. Mertsola,et al.  Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland , 2012, Clinical and Vaccine Immunology.

[12]  Robert S Ware,et al.  Number and order of whole cell pertussis vaccines in infancy and disease protection. , 2012, JAMA.

[13]  D. Hinton,et al.  The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA. , 2012, Microbiology.

[14]  D. Hozbor,et al.  Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America , 2012, Journal of applied microbiology.

[15]  M. Peeters,et al.  Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Y. Arakawa,et al.  Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan , 2012, PloS one.

[17]  C. Locht,et al.  The ins and outs of pertussis toxin , 2011, The FEBS journal.

[18]  S. Guillot,et al.  Significant Finding of Bordetella holmesii DNA in Nasopharyngeal Samples from French Patients with Suspected Pertussis , 2011, Journal of Clinical Microbiology.

[19]  P. van Damme,et al.  Rationale for pertussis booster vaccination throughout life in Europe. , 2011, The Lancet. Infectious diseases.

[20]  Who Publication Pertussis vaccines: WHO position paper--recommendations. , 2011, Vaccine.

[21]  A. Abe,et al.  Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis , 2011, PloS one.

[22]  N. Guiso,et al.  Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009. , 2010, Research in microbiology.

[23]  N. Carbonetti,et al.  Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. , 2010, Future microbiology.

[24]  T. Kallonen,et al.  Bordetella pertussis vaccine strains and circulating isolates in Serbia. , 2010, Vaccine.

[25]  U. Heininger Update on pertussis in children , 2010, Expert review of anti-infective therapy.

[26]  N. Guiso Bordetella pertussis and pertussis vaccines. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  G. Dore,et al.  First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. , 2009, Vaccine.

[28]  F. Mooi,et al.  Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. , 2009, Journal of microbiological methods.

[29]  F. Mooi,et al.  Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence , 2009, Emerging infectious diseases.

[30]  V. Chenal-Francisque,et al.  Genomic analysis of the adenylate cyclase-hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. , 2009, Research in microbiology.

[31]  N. Guiso,et al.  Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas. , 2008, Microbes and infection.

[32]  J. Mertsola,et al.  Bordetella pertussis isolates in Finland: Serotype and fimbrial expression , 2008, BMC Microbiology.

[33]  B. Soubeyrand,et al.  Pertussis Surveillance in Private Pediatric Practices, France, 2002–2006 , 2008, Emerging infectious diseases.

[34]  V. Caro,et al.  Genomic Content of Bordetella pertussis Clinical Isolates Circulating in Areas of Intensive Children Vaccination , 2008, PloS one.

[35]  V. Caro,et al.  Is the Sequenced Bordetella pertussis Strain Tohama I Representative of the Species? , 2008, Journal of Clinical Microbiology.

[36]  N. Guiso,et al.  Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. , 2007, Vaccine.

[37]  C. Locht,et al.  Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. , 2006, Microbes and infection.

[38]  J. Mertsola,et al.  Bordetella pertussis, Finland and France , 2006, Emerging infectious diseases.

[39]  F. Mooi,et al.  Bordetella pertussis, the Causative Agent of Whooping Cough, Evolved from a Distinct, Human-Associated Lineage of B. bronchiseptica , 2005, PLoS pathogens.

[40]  N. Guiso,et al.  Characterization of Adenylate Cyclase-Hemolysin Gene Duplication in a Bordetella pertussis Isolate , 2004, Infection and Immunity.

[41]  N. Fry,et al.  Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. , 2004, Journal of medical microbiology.

[42]  B. Barrell,et al.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica , 2003, Nature Genetics.

[43]  E. Hewlett,et al.  Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin–filamentous haemagglutinin interaction , 2002, Molecular microbiology.

[44]  F. Mooi,et al.  Multilocus Sequence Typing of Bordetella pertussis Based on Surface Protein Genes , 2002, Journal of Clinical Microbiology.

[45]  C. Boursaux-Eude,et al.  Polymorphism of Bordetella pertussisIsolates Circulating for the Last 10 Years in France, Where a Single Effective Whole-Cell Vaccine Has Been Used for More than 30 Years , 2001, Journal of Clinical Microbiology.

[46]  H. Hallander,et al.  Fimbrial Typing of Bordetella pertussis Isolates: Agglutination with Polyclonal and Monoclonal Antisera , 2001, Journal of Clinical Microbiology.

[47]  J. Brisson,et al.  Structure of the Bordetella pertussis 1414 endotoxin , 2000, FEBS letters.

[48]  F. Mooi,et al.  Epidemiological Typing of Bordetella pertussis Isolates: Recommendations for a Standard Methodology , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[49]  F. Mooi,et al.  Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. , 1999, Microbiology.

[50]  J. Desenclos,et al.  Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. , 1998, The Pediatric infectious disease journal.

[51]  S. Mboup,et al.  A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. , 1997, Vaccine.

[52]  F. Mooi,et al.  Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. , 1996, Microbiology.

[53]  P. François,et al.  Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France , 1996, Clinical and diagnostic laboratory immunology.

[54]  R. Matthews,et al.  Genetic relatedness of Bordetella species as determined by macrorestriction digests resolved by pulsed-field gel electrophoresis. , 1993, International journal of systematic bacteriology.

[55]  M. López [The genus Bordetella. By Manuel Moreno López, 1952]. , 1990 .

[56]  S. Toma,et al.  Bordetella pertussis serotypes in Canada. , 1978, Canadian Medical Association journal.

[57]  J. Nelson The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. , 1978, American journal of diseases of children.

[58]  D. Miller,et al.  The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period , 1976, Journal of Hygiene.

[59]  B. Lacey Antigenic modulation of Bordetella pertussis , 1960, Journal of Hygiene.

[60]  Marvin Israel Whooping Cough. By Joseph H. Lapin, B. Chem., M.D. , 1943 .

[61]  P. H. Leslie,et al.  The Phases of Haemophilus pertussis , 1931, Journal of Hygiene.

[62]  S. Guillot,et al.  Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome , 2012, European Journal of Clinical Microbiology & Infectious Diseases.